Biologics

LISCure Biosciences Announces Research Collaboration with The Scripps Research Institute for Immuno-Oncology

Scripps Research is the top nonprofit scientific institute in the US for producing high-quality research based on discoveries published in leading scientif...

 February 04, 2022 | News

IsoPlexis opens first APAC office

IsoPlexis, the Superhuman Cell Company, today announced the opening of its first office in the Asia-Pacific (APAC) region headed by Jason Ou as President/G...

 February 03, 2022 | News

Reaction Biology Announces Integrated Drug Discovery Solution

The Reaction Oncology Platform is based on a network of strategic partners, including oncology and biophysics by the US and Germany-based Reaction Biology,...

 February 03, 2022 | News

CAS, launches major biology expansion

CAS, a division of the American Chemical Society specializing in scientific information solutions, announces the launch of a major expansion of the CAS Sci...

 February 02, 2022 | News

Pfizer and Alex Therapeutics to provide evidence-based Digital Therapeutics to patients,

"In our efforts to give patients access to new, innovative forms of therapy, it is our aim to fully benefit from the possibilities of digitization. Alex Th...

 February 01, 2022 | News

Cytiva fuels biotech development in Australia and New Zealand

Cytiva, a global life sciences leader, announces the winner of its first BioChallenge for the Australia and New Zealand region (ANZ). T...

 February 01, 2022 | News

New Study Describes Novel Chemical Modifications to Fluorescent Dyes for Improved Super-Resolution Imaging by STORM

Biotium, a leading life science reagent supplier and producer of innovative dyes, has collaborated with Professor Ke Xu at University of California, Berkel...

 January 28, 2022 | News

Harbour Group's SpotSee Acquires the Assets of Biosynergy

Biosynergy manufactures and distributes temperature indicators used in the life sciences market, primarily in monitoring temperature on blood bags.  M...

 January 25, 2022 | News

Liminal BioSciences Announces Strategic Priorities for 2022

"2021 has been an important year for us: we have simplified our business strategy and created a liquidity reserve that will allow us to focus our resources...

 January 24, 2022 | News

Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings

Clinical Stage Asset Has Potential for First Approved Oral Therapy for Leber's Congenital Amaurosis (LCA) and Retinitis Pigmentosa (RP) Caused by Mutatio...

 January 20, 2022 | News

Australia (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

 January 20, 2022 | News

Dermaliq Therapeutics to Transform Drug Therapies into Clinical Trials

- Dermaliq Therapeutics, Inc. is an independent private pharmaceutical company emerged from Novaliq - Spin-off to unlock value in the space of medical der...

 January 19, 2022 | News

Seegene Unveils Blueprint for the Future of Molecular Diagnostics

Along with three solutions, he also introduced the company's automated, AI-enabled platform with a standard development tool that will empower users to eas...

 January 13, 2022 | News

Illumina collaborates with Nashville Biosciences to accelerate medicines development

 Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC)...

 January 11, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close